Articles avec comité de lecture de revues internationales

1 - 

The expanding roles of microRNAs in kidney pathophysiology

V. Metzinger-Le Meuth, O. Fourdinier, N. Charnaux, Z. Massy, L. Metzinger

Nephrology Dialysis Transplantation, 2019, 34, 7-15. 〈10.1093/ndt/gfy140〉. 〈hal-02061515〉

DOI : https://doi.org/10.1093/ndt/gfy140

 

2 - 

Exploring the Antimicrobial Action of Quaternary Amines against Acinetobacter baumannii

G. A. Knauf, A. L. Cunningham, M. I. Kazi, I. M. Riddington, A. A. Crofts, V. Cattoir, M. S. Trent, B. W. Davies

mBio, 2018, 9, e02394-17. 〈10.1128/mBio.02394-17〉. 〈hal-01718048〉

DOI : https://doi.org/10.1128/mBio.02394-17

Pubmed : 29437928

 

3 - 

Activity of fosfomycin alone or combined with temocillin in vitro and in a murine model of peritonitis due to KPC-3- or OXA-48-producing Escherichia coli

M. Berleur, F. Guérin, L. Massias, F. Chau, J. Poujade, V. Cattoir, B. Fantin, V. De Lastours

Journal of Antimicrobial Chemotherapy, 2018, 73, 3074-3080. 〈10.1093/jac/dky283〉. 〈hal-01862605〉

DOI : https://doi.org/10.1093/jac/dky283

Pubmed : 30085154

 

4 - 

Live intramacrophagic Staphylococcus aureus as a potential cause of antibiotic therapy failure observations in an in vivo mouse model of prosthetic vascular material infections

R. Boudjemaa, K. Steenkeste, C. Jacqueline, R. Briandet, J. Caillon, D. Boutoille, V. Le Mabecque, P. Tattevin, M.-P. Fontaine-Aupart, M. Revest

Journal of Antimicrobial Chemotherapy, 2018, 73, pp.2418-2421. 〈10.1093/jac/dky205〉. 〈hal-01834453v2〉

DOI : https://doi.org/10.1093/jac/dky205

Pubmed : 29901764

 

5 - 

How is fosfomycin resistance developed in Escherichia coli?

V. Cattoir, F. Guerin

Future Microbiology, 2018, 〈10.2217/fmb-2018-0294〉. 〈hal-02020815〉

DOI : https://doi.org/10.2217/fmb-2018-0294

Pubmed : 30526061

 

6 - 

Modulation of Bacterial sRNAs Activity by Epigenetic Modifications Inputs from the Eukaryotic miRNAs

B. Felden, D. Gilot

Genes, 2018, 10, E22. 〈10.3390/genes10010022〉. 〈hal-01993659〉

DOI : https://doi.org/10.3390/genes10010022

Pubmed : 30602712

 

7 - 

Bacterial adaptation to antibiotics through regulatory RNAs

B. Felden, V. Cattoir

Antimicrobial Agents and Chemotherapy, 2018, 62, e02503-17. 〈10.1128/AAC.02503-17〉. 〈hal-01764887〉

DOI : https://doi.org/10.1128/AAC.02503-17

Pubmed : 29530859

 

8 - 

A novel Staphylococcus aureus cis-trans type I toxin-antitoxin module with dual effects on bacteria and host cells

N. Germain-Amiot, Y. Augagneur, E. Camberlein, I. Nicolas, V. Lecureur, A. Rouillon, B. Felden

Nucleic Acids Research, 2018, 〈10.1093/nar/gky1257〉. 〈hal-01976467〉

DOI : https://doi.org/10.1093/nar/gky1257

Pubmed : 30544243

 

9 - 

Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe Towards a common nomenclature

J. K. Bender, V. Cattoir, K. Hegstad, E. Sadowy, T. M. Coque, H. Westh, A. M. Hammerum, K. Schaffer, K. Burns, S. Murchan, C. Novais, A. R. Freitas, L. Peixe, M. Del Grosso, A. Pantosti et al.

Drug Resistance Updates, 2018, 40, 25-39. 〈10.1016/j.drup.2018.10.002〉. 〈hal-01940265〉

DOI : https://doi.org/10.1016/j.drup.2018.10.002

Pubmed : 30447411

 

10 - 

Selective recovery of RNAs from bacterial pathogens after their internalization by human host cells

S. Raynaud, H. Le Pabic, B. Felden

Methods, 2018, 143, 4-11. 〈10.1016/j.ymeth.2018.04.035〉. 〈hal-01861200v2〉

DOI : https://doi.org/10.1016/j.ymeth.2018.04.035

Pubmed : 29709561